You can now review and comment on this draft guideline.
The consultation closes on 5pm on 13th September 2019
How to comment
1. Register your organisation or comment as an individual
If you’re commenting for an organisation, your organisation needs to be registered as a stakeholder.
Not eligible? Contact the stakeholder organisation that most closely represents your interests and pass your comments to them.
We can accept comments from individuals. These will be considered, but you won’t get a formal response and they won’t be posted on the NICE website. Wherever possible we encourage you to submit your comments through a registered stakeholder organisation.
2. Read the consultation documents
Documents to comment on:
- Draft guideline– just the recommendations
- Evidence reviews:
Evidence review A1 - Prevention of CRC in people with Lynch syndromes
Evidence review B1 - Molecular biomarkers
Evidence review C1 - Early rectal cancer
Evidence review C2 - Preoperative therapy for rectal cancer
Evidence review C3 - Surgical technique for rectal cancer
Evidence review C4 - Deferral of surgery for rectal cancer
Evidence review C5 - Pelvic exenteration
Evidence review C6 - Endoscopic resection along for early colon cancer
Evidence review C7 - Preoperative chemotherapy for colon cancer
Evidence review C8 - Duration of adjuvant chemotherapy
Evidence review C9 - Colonic stenting
Evidence review D1 - Asymptomatic primary tumour
Evidence review D2a - Metastatic CRC in the liver amenable to treatment with curative intent
Evidence review D2b - Metastatic CRC in the liver not amenable to treatment with curative intent
Evidence review D3 - Metastic CRC in the lung
Evidence review D4 - Metastatic CRC in the periotoneum
Evidence review E1 - Follow-up
Evidence review E2 - Management of LARS
Evidence review E3 - Information needs
Evidence review F1 - Surgical volumes
- Supporting documentation:
Supporting documentation 1 - Methods
Supporting documentation 2 - Health economics
Supporting documentation 3 - Glossary
Supporting documentation 4 - NGA team list
- Economic models
If you want to review the economic models, please see 5. Economic models below and fill in the confidentiality form.
Other information about the consultation
- Equality impact assessment
- Committee membership list and DOI register
- Developing NICE guidelines: how to get involved
3. Add your comments
- You must use this comments form.
- You must declare any links with, or funding from, the tobacco industry
If you share similar views with another organisation, send a joint response.
Make sure you consider:
- The areas that will have the biggest impact on practice and be challenging to implement
- How to help users overcome challenges
Developing NICE guidelines: how to get involved suggests some other areas to comment on.
4. Email the form to us
Deadline: 5pm on 13th September 2019
5. Economic model
The developer has produced an economic model to support the guideline on Colorectal cancer: diagnosis and management (update). To receive an executable version of this model, please submit a request to ColorectalCancer@nice.org.uk with a signed copy of the confidentiality acknowledgement and undertaking form.
We will then send you a link to an executable version of the economic model by email. The deadline for returning your comments is the same as for the guideline consultation:5pm on 13th September 2019.
This page was last updated: 03 January 2020